Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 104923
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104923
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104923
Table 2 Comparison of peripheral blood natural killer T cell subset levels between the two groups (mean ± SD)
Indicators | PLC group (n = 30) | Control group (n = 30) | t | P value |
CD4+NKT | 5.52 ± 0.88 | 5.18 ± 0.94 | 1.446 | 0.154 |
CD8+NKT | 3.12 ± 0.37 | 3.09 ± 0.46 | 0.278 | 0.782 |
CD3+CD56+NKT | 6.68 ± 0.52 | 6.47 ± 0.63 | 1.408 | 0.165 |
CD8+CD56+NKT | 8.35 ± 1.01 | 6.77 ± 0.74 | 6.912 | < 0.001 |
CD3+CD161+NKT | 14.36 ± 1.55 | 12.82 ± 1.87 | 3.473 | 0.001 |
CD3-CD161+NKT | 12.08 ± 1.34 | 7.69 ± 0.93 | 14.742 | < 0.001 |
- Citation: Zhou ST, Zhang B, Ma K, Guo J. Clinical significance of immune cell and biomarker changes in liver cancer. World J Gastrointest Surg 2025; 17(6): 104923
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/104923.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.104923